Search results for "Highlights"
AI-assisted colonoscopy does not improve detection of advanced neoplasias
While colonoscopies with artificial intelligence (AI) assistance yielded more adenomas compared with conventional colonoscopy, rates of advanced neoplasias per colonoscopy did not differ, a systematic review and meta-analysis found.
https://gastroenterology.acponline.org/archives/2024/10/25/2.htm
25 Oct 2024
Subscribe
ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.
https://gastroenterology.acponline.org/subscribe/index.html
Elimination diets, PPIs most cost-effective for EoE treatment
Elimination diets were the most cost-effective strategy for treatment of eosinophilic esophagitis (EoE) over a five-year period, while proton-pump inhibitors (PPIs) were the most cost-effective first-line drugs, a recent study found.
https://gastroenterology.acponline.org/archives/2024/10/25/3.htm
25 Oct 2024
Spotlight on liver health in diabetes
A review compared liver outcomes for most classes of diabetes drugs, while a retrospective study looked at glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors head to head. Another study offered a new score for metabolic dysfunction-associated steatotic liver disease.
https://gastroenterology.acponline.org/archives/2024/10/25/8.htm
25 Oct 2024
In the Clinic, 2023 summary highlight gastroenterology topics
Colorectal cancer screening was the focus of the latest In the Clinic article, while an article in a supplement to Annals reviewed clinically important developments in gastroenterology and hepatology in 2023.
https://gastroenterology.acponline.org/archives/2024/04/26/5.htm
26 Apr 2024
Combined FIT, H. pylori testing not linked with lower gastric cancer mortality
Inviting patients to get both Helicobacter pylori stool antigen testing and a fecal immunochemical test (FIT) was associated with lower gastric cancer incidence than FIT alone after adjustment, but no change in related mortality, according to a Taiwanese trial.
https://gastroenterology.acponline.org/archives/2024/10/25/1.htm
25 Oct 2024
FIB-4 may identify patients at risk for MASLD despite normal aminotransferase levels
More than two-thirds of primary care patients who had high or indeterminate risk for metabolic dysfunction-associated steatotic liver disease (MASLD) based on the fibrosis-4 (FIB-4) score had aminotransferase levels within normal limits.
https://gastroenterology.acponline.org/archives/2024/08/23/2.htm
23 Aug 2024
Fecal immunochemical tests vary widely in sensitivity, specificity
The test positivity rate among five commonly used fecal immunochemical tests varied from 3.9% to 16.4%, and rates of unevaluable tests ranged from 0.2% to 2.5%. The sensitivity for advanced neoplasia varied from 10.1% to 36.7%, and specificity varied from 85.5% to 96.6%.
https://gastroenterology.acponline.org/archives/2024/09/27/2.htm
27 Sep 2024
Clinical practice update advises on management of cyclic vomiting syndrome
A basic workup for episodic vomiting should include bloodwork and urinalysis, and management of cyclic vomiting syndrome often entails multiple abortive medications, the American Gastroenterological Association said.
https://gastroenterology.acponline.org/archives/2024/07/26/3.htm
26 Jul 2024
GLP-1 receptor agonists associated with retention of gastric contents during endoscopy
Patients taking glucagon-like peptide-1 (GLP-1) receptor agonists did not have any increase in upper endoscopy adverse events, a review found, leading the authors to suggest that longer fasting time before procedures would be sufficient to avoid the risks.
https://gastroenterology.acponline.org/archives/2024/08/23/3.htm
23 Aug 2024